Results of a “groundbreaking” study could have the potential to extend the lives of thousands of Dobermann pinschers prone to developing dilated cardiomyopathy (DCM).
The PROTECT study is the first prospective, blinded study in veterinary cardiology of its kind to demonstrate a significant benefit of treating dogs in the pre-clinical phase of DCM.
Results of the PROTECT study – dubbed “a world first in veterinary cardiology” – will be revealed at BSAVA Congress (april 9-12) by Boehringer Ingelheim Vetmedica, makers of Vetmedin.
The Vetmedin team will be communicating the results of this groundbreaking study through a series of announcements and activities, and vets will be encouraged to re-evaluate their approach to pre-clinical DCM.
Throughout congress there will also be the opportunity to enter a photo competition
to win a series of prizes, which will increase in value as the number of entries increases – including the daily opportunity to win a coveted Apple iWatch, worth £479
Visitors to stand 431 will also be able to pose in the Vetmedin “heart” installation to have their photo taken. The photos will be uploaded to an album on the vetsonline Facebook page for sharing with the hashtag #InMyHands to show commitment from veterinary professionals to “help DCM patients live longer, better lives“.